Stamford-based Purdue Pharma LP recently named Dr. Gail Cawkwell, former vice president in the medicines development group at Pfizer, as vice president of medical affairs, a new position.
“Gail brings to Purdue strong credentials and broad and relevant skills in all aspects of medical affairs, including drug development and regulatory and commercial planning,” said Mark Timney, president and CEO of Purdue Pharma, in a statement. “I’m confident that Gail’s experience as a physician leader will help us continue serving our patients and customers.”
Cawkwell has more than 13 years of pharmaceutical development and medical affairs experience in multiple disease areas. Her roles at Pfizer included vice president of medical affairs and vice president of medicine team lead for Xeljanz, an arthritis drug.
“I am excited to join a company focused on health care system innovation and bringing vital treatment options to patients,” Cawkwell said in a statement.
